Mexico Onychomycosis Market Size & Outlook, 2023-2030
Mexico onychomycosis market, 2018-2030 (US$M)
Related Markets
Mexico onychomycosis market highlights
- The Mexico onychomycosis market generated a revenue of USD 45.2 million in 2023 and is expected to reach USD 68.8 million by 2030.
- The Mexico market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
- In terms of segment, topical was the largest revenue generating treatment in 2023.
- Topical is the most lucrative treatment segment registering the fastest growth during the forecast period.
Onychomycosis market data book summary
| Market revenue in 2023 | USD 45.2 million |
| Market revenue in 2030 | USD 68.8 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Topical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Topical |
| Key market players worldwide | GSK PLC, Abbott Laboratories, Pfizer Inc, Bausch Health Companies Inc, Bayer AG, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Merck & Co Inc, Novartis AG ADR, Sun Pharmaceutical Industries |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.3% of the global onychomycosis market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil onychomycosis market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 68.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Onychomycosis Market Scope
Onychomycosis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico onychomycosis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to onychomycosis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 57.74% in 2023. Horizon Databook has segmented the Mexico onychomycosis market based on oral, topical covering the revenue growth of each sub-segment from 2018 to 2030.
Several R&D initiatives and collaborations to advance onychomycosis treatment options drive the onychomycosis market in Mexico.
For instance, the MDPI published an article in May 2023 by doctors from the dermatology department from Universidad Autónoma de Nuevo León in Mexico in collaboration with the Department of Dermatology in University of Miami Miller School of Medicine in the U.S.
It stated that onychomycosis, caused by dermatophytes, yeasts, and Nondermatophyte Moulds (NDMs), often requires oral treatment for moderate to severe cases, multiple-digit involvement, or when topical therapies are ineffective.
Reasons to subscribe to Mexico onychomycosis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico onychomycosis market databook
-
Our clientele includes a mix of onychomycosis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico onychomycosis market , including forecasts for subscribers. This country databook contains high-level insights into Mexico onychomycosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico onychomycosis market size, by treatment, 2018-2030 (US$M)
Mexico Onychomycosis Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
